Form 8-K - Current report:
SEC Accession No. 0000950123-11-085229
Filing Date
2011-09-19
Accepted
2011-09-19 17:01:18
Documents
3
Period of Report
2011-09-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y92668e8vk.htm 8-K 13418
2 EX-99.1 y92668exv99w1.htm EX-99.1 643422
3 GRAPHIC y92668y9266800.gif GRAPHIC 9629
  Complete submission text file 0000950123-11-085229.txt   671633
Mailing Address MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY PARSIPPANY NJ 07054
Business Address MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY PARSIPPANY NJ 07054 9092701400
WATSON PHARMACEUTICALS INC (Filer) CIK: 0000884629 (see all company filings)

EIN.: 953872914 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13305 | Film No.: 111097775
SIC: 2834 Pharmaceutical Preparations